Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Cannabidiol Capsule Usage as an Adjunct Therapy for Crohn's Disease: a Randomized, Placebo-controlled Study

NCT03467620 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.

NCT NCT03467620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03467620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Cannabidiol Capsule Usage as an Adjunct Therapy for Crohn's Disease: a Randomized, Placebo-controlled Study
Lead sponsor
University of Illinois at Chicago
Phase
Phase 2/3
Overall status
Withdrawn
Start date
July 31, 2018
Completion date
July 31, 2019
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cannabis, crohn disease, inflammatory bowel diseases